Medarex and Epigen to develop cancer antibodies

MEDX and Epigen (Millbrook, N.Y.) will develop antibody-based cancer therapeutics, using MEDX's HuMAb-Mouse technology to produce human antibodies against Epigen's targets, including its Human Carcino...